Id http://purl.obolibrary.org/obo/NCIT_C1831
http://purl.obolibrary.org/obo/NCIT_C1831
Preferred Name

Semaxanib

Definitions
A quinolone derivative with potential antineoplastic activity. Semaxanib reversibly inhibits ATP binding to the tyrosine kinase domain of vascular endothelial growth factor receptor 2 (VEGFR2), which may inhibit VEGF-stimulated endothelial cell migration and proliferation and reduce the tumor microvasculature. This agent also inhibits the phosphorylation of the stem cell factor receptor tyrosine kinase c-kit, often expressed in acute myelogenous leukemia cells.
Type http://www.w3.org/2002/07/owl#Class
Delete Subject Author Type Created
No notes to display